Status:
COMPLETED
Non-OpeRative MANagement of Rectal Cancer Patients
Lead Sponsor:
Kangbuk Samsung Hospital
Conditions:
Rectal Cancer
Chemoradiotherapy
Eligibility:
All Genders
20-100 years
Phase:
PHASE2
Brief Summary
This study is a single-center, open, prospective, single-treatment trial (pilot study). This study aims to analyze the treatment results after receiving capecitabine adjuvant chemotherapy for 4 months...
Detailed Description
Indication: 1. mid-to-lower rectal cancer was diagnosed histologically as adenocarcinoma in preoperative examination, 2. the tumor was located at the lower boundary of the tumor spans the anorectal j...
Eligibility Criteria
Inclusion
- Clinical CR after pre-operative CRT for Rectal cancer
Exclusion
- \-
Key Trial Info
Start Date :
February 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2024
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT04696757
Start Date
February 1 2018
End Date
December 31 2024
Last Update
February 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kangbuk Samsung Hospital
Seoul, South Korea, 110-746